What this means
This is a trial that is still signing people up, so no results exist yet. It will check if an exercise program can be carried out well in people getting a stem cell transplant.
Plain-English summary written by an AI model from the registry listing.
- Status
- Recruiting
- Who can join
- Ages 60 and over · Up to 72 people getting a stem cell transplant, planned; no results yet
- Where
- 1 site, including Pennsylvania
The science
- Registered title
- Improve Outcomes for Older Allogeneic Transplant Recipients
- Trial ID
- NCT05612789 ↗
- Phase
- Not applicable
- Study type
- interventional
- Conditions
- Allogeneic Transplantation
- What is tested
- Exercise Program (Cohort A Prehab), Exercise Program (Cohort B Rehab)
- Sponsor
- Abramson Cancer Center at Penn Medicine
- Ages
- 60 Years to no maximum
- Dates
- First posted Nov 10, 2022 · updated Dec 10, 2025
Registry summary
This is an interventional pilot study to determine whether implementation of a supervised exercise program can improve outcomes in subjects undergoing allogeneic HCT. The primary objective is to determine feasibility. Up to 60-72 evaluable subjects will be enrolled. Evaluable subjects are defined as those participating in the exercise intervention.
Sites (1)
- Penn Medicine, Philadelphia, Pennsylvania, United States